Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Hot flashes

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    36 result(s) found for: Hot flashes. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2015-002578-20 Sponsor Protocol Number: ESN364_HF_204 Start Date*: 2015-08-25
    Sponsor Name:Euroscreen S.A
    Full Title: Pilot/Phase IIa Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes
    Medical condition: hot flashes
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004866 10020407 Hot flashes LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2009-016070-33 Sponsor Protocol Number: 6913-004 Start Date*: 2010-01-20
    Sponsor Name:Merck & Co., Inc.
    Full Title: A Phase IIa, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of MK-6913 for the Treatment of Vasomotor Symptoms in Postmenopausal W...
    Medical condition: Vasomotor symptoms (hot flashes)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10060800 Hot flush LLT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Prematurely Ended) BE (Completed) SE (Prematurely Ended) DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001322-25 Sponsor Protocol Number: A4291023 Start Date*: 2006-07-20
    Sponsor Name:Pfizer, S.A.
    Full Title: A PHASE 2b MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY EVALUATING THE EFFICACY AND SAFETY OF PD 0299685 FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPT...
    Medical condition: Treatment of moderate to severe vasomotor symptoms (hot flushes) associated with menopause
    Disease: Version SOC Term Classification Code Term Level
    8.1 10020408 Hot flushes LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2022-000095-18 Sponsor Protocol Number: 21656 Start Date*: 2022-09-12
    Sponsor Name:Bayer Consumer Care AG
    Full Title: A double-blind, randomized, placebo-controlled multicenter study to investigate efficacy and safety of elinzanetant for the treatment of vasomotor symptoms caused by adjuvant endocrine therapy, ove...
    Medical condition: Vasomotor symptoms caused by adjuvant endocrine therapy in women with, or at high risk for developing hormone-receptor positive breast cancer
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10022457 Instability vasomotor LLT
    21.0 10047065 - Vascular disorders 10020407 Hot flashes LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Trial now transitioned) HU (Trial now transitioned) ES (Trial now transitioned) FI (Trial now transitioned) BE (Trial now transitioned) FR (Trial now transitioned) PT (Trial now transitioned) IE (Trial now transitioned) IT (Trial now transitioned) RO (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2015-001553-32 Sponsor Protocol Number: MR/M024954/1 Start Date*: 2015-10-09
    Sponsor Name:Imperial College, Joint Research Compliance Office
    Full Title: Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes
    Medical condition: menopausal hot flushes
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004872 10027311 Menopause flushing LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-016959-21 Sponsor Protocol Number: BRN-2009-03 Start Date*: 2010-02-19
    Sponsor Name:LABORATOIRES BOIRON
    Full Title: Etude contrôlée, randomisée en double aveugle versus placebo de l’efficacité de la spécialité homéopathique BRN-01 dans le traitement des bouffées de chaleur de la femme ménopausée
    Medical condition: Bouffées de chaleur de la femme ménopausée
    Disease: Version SOC Term Classification Code Term Level
    12.1 10027301 Menopausal hot flushes LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FR (Ongoing)
    Trial results: View results
    EudraCT Number: 2018-002763-26 Sponsor Protocol Number: 814-PM-02 Start Date*: 2019-01-17
    Sponsor Name:NeRRe Therapeutics Ltd,
    Full Title: A DOUBLE-BLIND, RANDOMISED, PLACEBO CONTROLLED, ADAPTIVE DESIGN STUDY OF THE EFFICACY, SAFETY AND PHARMACOKINETICS OF NT-814 IN FEMALE SUBJECTS WITH MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED...
    Medical condition: Hot flushes (vasomotor symptoms) in menopausal women
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10027311 Menopause flushing LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-000472-14 Sponsor Protocol Number: 177001 Start Date*: 2004-11-17
    Sponsor Name:Organon Hungary Ltd.
    Full Title: A multicenter, randomized, parallel-group, double- blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe va...
    Medical condition: moderate to severe vasomotor symptoms associated with the menopause
    Disease: Version SOC Term Classification Code Term Level
    7.0 10020411 LLT
    Population Age: Adults Gender: Female
    Trial protocol: HU (Completed) CZ (Completed) SK (Completed) ES (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-004246-41 Sponsor Protocol Number: RG_13-198 Start Date*: 2015-01-26
    Sponsor Name:Sandwell and West Birmingham Hospitals NHS Trust [...]
    1. Sandwell and West Birmingham Hospitals NHS Trust
    2. University of Birmingham
    Full Title: A phase III randomised study of folic acid supplementation in the management of menopausal symptoms in cancer survivors and healthy postmenopausal women
    Medical condition: Menopause Symptoms
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004872 10027311 Menopause flushing LLT
    18.0 10041244 - Social circumstances 10028812 Natural menopause LLT
    18.0 10041244 - Social circumstances 10027308 Menopause PT
    18.0 10041244 - Social circumstances 10051775 Postmenopause PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-011546-26 Sponsor Protocol Number: LCF-GIN-2008-EC02 Start Date*: 2009-08-07
    Sponsor Name:LABORATORIOS CASEN FLEET S.L.U
    Full Title: ENSAYO CLÍNICO ALEATORIZADO, DOBLE-CIEGO Y CONTROLADO CON PLACEBO, PARA EVALUAR LA EFICACIA Y TOLERABILIDAD DE LA COMBINACIÓN DE ISOFLAVONAS DE SOJA Y EXTRACTO DE TRÉBOL ROJO (FITOGYN) EN EL TRATAM...
    Medical condition: TRATAMIENTO DE SINTOMATOLOGIA VASOMOTORA MODERADA EN MUJERES POSTMENOPÁUSICAS + TREATMENT OF MODERATE VASOMOTOR SYMPTOMS IN POSTMENOPAUSAL WOMEN
    Disease: Version SOC Term Classification Code Term Level
    9 10020417 Hot flushes, menopausal LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-003529-27 Sponsor Protocol Number: 2693-CL-0302 Start Date*: 2019-10-03
    Sponsor Name:Astellas Pharma Global Development, Inc.
    Full Title: A Phase 3, Randomized, Placebo-controlled, 12-week Double-blind Study, followed by a Non- Controlled Extension Treatment Period, to Assess the Efficacy and Safety of Fezolinetant in Women Suffering...
    Medical condition: Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004866 10020407 Hot flashes LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) LV (Completed) CZ (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2004-000469-36 Sponsor Protocol Number: 46101 Start Date*: 2004-11-08
    Sponsor Name:NV Organon
    Full Title: A multicenter, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the efficacy and safety of four different doses of Org 50081 in the treatment of moderate to severe vas...
    Medical condition: moderate to severe vasomotor symptoms associated with the menopause
    Disease: Version SOC Term Classification Code Term Level
    7.0 10020411 LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed) FI (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-005071-17 Sponsor Protocol Number: 15-50615 Start Date*: 2006-11-06
    Sponsor Name:Hormos Medical Ltd
    Full Title: Preliminary efficacy of OphenaTM (ospemifene) in the treatment of vasomotor symptoms associated with the menopause: a 6-week, randomized, double-blind, placebo-controlled, parallel-group study
    Medical condition: Postmenopausal symptoms (hot flashes)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10050903 Postmenopausal symptoms LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001372-75 Sponsor Protocol Number: I2B-MC-GACB Start Date*: 2008-06-03
    Sponsor Name:Chorus, a Division of Eli Lilly and Company
    Full Title: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2245461 after Multiple Oral Administrations in Healthy Postmenopausal Women
    Medical condition: Reduce the number of hot flushes for postmenopausal women
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2019-000275-16 Sponsor Protocol Number: 2693-CL-0304 Start Date*: 2019-09-03
    Sponsor Name:Astellas Pharma Global Development, Inc.
    Full Title: A Randomized, Placebo-controlled, Double-blind Phase 3 Clinical Study to Investigate the Long-Term Safety of Fezolinetant in Women Suffering from Vasomotor Symptoms (Hot Flashes) Associated with Me...
    Medical condition: Vasomotor Symptoms (Hot Flashes) Associated with Menopause
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004866 10020407 Hot flashes LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) PL (Completed) LV (Completed) ES (Completed) CZ (Completed) HU (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2019-002281-12 Sponsor Protocol Number: SJX-653-006 Start Date*: 2019-12-03
    Sponsor Name:Sojournix, Inc.
    Full Title: A phase 2, prospective, randomized, double-blind, placebo-controlled clinical study to assess the efficacy, safety, tolerability, and pharmacokinetics of SJX-653 in postmenopausal women with modera...
    Medical condition: Treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004872 10027311 Menopause flushing LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) PL (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) BE (Completed)
    Trial results: View results
    EudraCT Number: 2018-003528-35 Sponsor Protocol Number: 2693-CL-0301 Start Date*: 2019-11-22
    Sponsor Name:Astellas Pharma Global Development, Inc.
    Full Title: A Phase 3, Randomized, Placebo-controlled, 12-week Double-blind Study, followed by a Non-Controlled Extension Treatment Period, to Assess the Efficacy and Safety of Fezolinetant in Women Suffering ...
    Medical condition: Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004866 10020407 Hot flashes LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) ES (Completed) CZ (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2007-003731-23 Sponsor Protocol Number: 1 Start Date*: 2008-04-30
    Sponsor Name:Österreichische Gesellschaft zur Erforschung komplementär – alternativer Therapien in der Onkologie
    Full Title: Effects of pomegrante seed oil on menopausal symptoms
    Medical condition: hot flashes, menopausal symptoms
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011527-31 Sponsor Protocol Number: V1.4 Start Date*: 2009-12-02
    Sponsor Name:Medizinische Universität Wien, Univ.Klinik KIM II, Abteilung für Kardiologie
    Full Title: Effect of Nebivolol on climacteric disorders in postmenopausal women: A pilot study
    Medical condition: postmenopausal women
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2007-004791-39 Sponsor Protocol Number: 57019085 Start Date*: 2008-04-22
    Sponsor Name:Vejle Hospital
    Full Title: Et prospektivt randomiseret fase II studie til evaluering af Gabapentin og Venlafaxin´s virkning mod hedestigninger hos kvinder opereret for brystkræft og i antihormonbehandling i form af arom...
    Medical condition: Patients in adjuvant aromatase inhibitor treatment for breast cancer having serious side effects conserning hot flashes affecting daily life.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 09:16:45 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA